FORWARD LOOKING STATEMENTS

This quarterly report contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "may", "should", "expects", "plans", "anticipates", "believes", "estimates", "predicts", "potential" or "continue" or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

Our unaudited financial statements are stated in United States Dollars (US$) and are prepared in accordance with United States Generally Accepted Accounting Principles. The following discussion should be read in conjunction with our financial statements and the related notes that appear elsewhere in this quarterly report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed below and elsewhere in this quarterly report.

Our financial statements are stated in United States Dollars (US$) and are prepared in accordance with United States Generally Accepted Accounting Principles.

In this quarterly report, unless otherwise specified, all dollar amounts are expressed in United States dollars and all references to "common shares" refer to the common shares in our capital stock.

As used in this quarterly report, the terms "we", "us", "our" and "our company" mean Excellerant, Inc., unless otherwise indicated.





General Overview

Excellerant, Inc. was incorporated in the State of Nevada on May 30, 2019. Our company is planning to offer a broad range of health advisory and tour services: consulting services in the field of traditional and alternative medicine and medical technologies in China; helping our customers to choose a clinic for treatment; consulting customers and helping them to arrange the itinerary, by building a route, which includes clinics, hospitals and other medical institution; providing guide services to our potential clients. We also provide them with information concerning tr ansportation, the cost of it, how it operates and what are the best medical institutions. We are going to provide our services both to legal entities and individuals.

We do not currently have any arrangements for additional financing. Our principal executive offices are located at 302 Yayun Ave, Panyu, Guangzhou, Guangdong 510000, China. Our phone +17027769823

We are a developing stage company. From inception until the date of this filing, we have had limited operating activities. Our financial statements from Inception through March 31, 2021 reports $48 fund held in escrow and had an accumulated deficit of $29,135. Our independent registered public accounting firm has issued an audit opinion that includes a statement expressing substantial doubt as to our company's ability to continue as a going concern.






         11

  Table of Contents

We do not have any subsidiaries.

We have never declared bankruptcy, been in receivership, or involved in any kind of legal proceeding.





Results of Operation

The following summary of our operations should be read in conjunction with our unaudited financial statements for the six months ended March 31, 2021 and 2020.

We have not earned any revenues from our inception through March 31, 2021.

Three months ended March 31, 2021 compared to three months ended March 31, 2020





                       Three Months Ended
                            March 31,                 Changes
                        2021          2020        Amount        %

Operating Expenses   $   (5,300 )   $ (5,980 )   $    680       (11 %)
Other income             29,832            -       29,832       100 %
Net Income (Loss)    $   24,532     $ (5,980 )   $ 30,512      (510 %)

Our net income for the three months ended March 31, 2021 was $24,532 compared with net loss of $5,980 for the three months ended March 31, 2020 due to the increase in other income. During the three months ended March 31, 2021, we recognized forgiveness of loans from the former director of the Company of $29,832 upon his resignation on March 31, 2021.

Six months ended March 31, 2021 compared to six months ended March 31, 2020





                        Six Months Ended
                            March 31,                  Changes
                       2021          2020         Amount         %

Operating expenses   $ (26,100 )   $ (13,793 )   $ (12,307 )      89 %
Other income            29,832             -        29,832       100 %
Net Income (Loss)    $   3,732     $ (13,793 )   $  17,525      (127 %)

Our net income for the six months ended March 31, 2021 was $3,732 compared with net loss of $13,793 for the six months ended March 31, 2020 due to the increase in other income. During the six months ended March 31, 2021, we recognized forgiveness of loans from the former director of the Company of $29,832 upon his resignation on March 31, 2021.






         12

  Table of Contents




Liquidity and Capital



Working Capital



                                As of             As of
                              March 31,       September 30,           Changes
                                2021              2020            Amount        %

Current Assets               $        48     $        20,745     $ (20,697 )   (100 %)
Current Liabilities          $     2,403     $        26,832     $ (24,429 )    (91 %)
Working Capital Deficiency   $    (2,355 )   $        (6,087 )   $   3,732      (61 %)

As at March 31, 2021 and September 30, 2020 our company had 448 and $20,745 held in the escrow account, respectively.

As at March 31, 2021, our company had total current liabilities of $2,403from accounts payable and accrued liabilities. As at September 30, 2020, our company had total current liabilities of $26,832, of which included accounts payable from the former director's accrued consulting fees of $16,000 and former director loan of $10,832.

As at March 31, 2021, our company had a working capital deficiency of $2,355 compared with a working capital deficiency of $6,087 as at September 30, 2020. The decrease in working capital deficit was primarily due to the forgiveness of the loans from the former director of $29,832.





Cash Flows



                                                 Six Months Ended
                                                    March 31,                  Changes
                                                2021          2020        Amount         %

Cash flows used in operating activities $ (20,697 ) $ (7,793 ) $ (12,904 ) 166 % Cash flows used in investing activities

               -            -             -         0 %
Cash flows provided by financing activities           -       11,973       (11,973 )    (100 %)
Net changes in cash                           $ (20,697 )   $  4,180     $ (24,877 )    (595 %)

Cash Flow from Operating Activities

We have not generated positive cash flow from operating activities. During the six months ended March 31, 2021, net cash used in operating activities was $20,697 compared to $7,793 used during the six months ended March 31, 2020. Cash flows used in operating activities during the six months ended March 31, 2021, comprised of a net income of $3,732, which was increased by an increase in accounts payable and accrued liabilities of $2,403 and reduced by forgiveness of loans of $26,832. Cash flows used in operating activities during the six months ended March 31, 2020, comprised of a net loss from of $13,793, which was reduced by an increase in accounts payable and accrued liabilities of $6,000.






         13

  Table of Contents

Cash Flow from Investing Activities

During the six months ended March 31, 2021 and 2020, our company did not have any investing activities.

Cash Flow from Financing Activities

During the six months ended March 31, 2021, net cash provided by financing activities was $nil compared to $11,973 during the six months ended March 31, 2020. During the six months ended March 31, 2020, the Company received $4,200 from issuance of common stock and $7,773 from advancement from director of the Company.

Plan of Operation and Funding

We expect that working capital requirements will continue to be funded through a combination of our existing funds and further issuances of securities. Our working capital requirements are expected to increase in line with the growth of our business.

Existing working capital, further advances and debt instruments, and anticipated cash flow are expected to be adequate to fund our operations over the next three months. We have no lines of credit or other bank financing arrangements. Generally, we have financed operations to date through the proceeds of the private placement of equity and debt instruments. In connection with our business plan, management anticipates additional increases in operating expenses and capital expenditures relating to: (i) acquisition of inventory; (ii) developmental expenses associated with a start-up business; and (iii) marketing expenses. We intend to finance these expenses with further issuances of securities, and debt issuances. Thereafter, we expect we will need to raise additional capital and generate revenues to meet long-term operating requirements. Additional issuances of equity or convertible debt securities will result in dilution to our current shareholders. Further, such securities might have rights, preferences or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, we may not be able to take advantage of prospective new business endeavors or opportunities, which could significantly and materially restrict our business operations. We will have to raise additional funds in the next twelve months in order to sustain and expand our operations. We currently do not have a specific plan of how we will obtain such funding; however, we anticipate that additional funding will be in the form of equity financing from the sale of our common stock. We have and will continue to seek to obtain short-term loans from our directors, although no future arrangement for additional loans has been made. We do not have any agreements with our directors concerning these loans. We do not have any arrangements in place for any future equity financing.

Off-Balance Sheet Arrangements

As of the date of this Quarterly Report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.





Going Concern

The independent auditors' review report accompanying our March 31, 2021 financial statements contained an explanatory paragraph expressing substantial doubt about our ability to continue as a going concern. The financial statements have been prepared "assuming that we will continue as a going concern," which contemplates that we will realize our assets and satisfy our liabilities and commitments in the ordinary course of business.






         14

  Table of Contents

© Edgar Online, source Glimpses